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Abstract
Background: Both low birth weight, an indicator of intrauterine growth restriction, and low grade systemic
inflammation depicted by high sensitivity C-reactive protein (hs-CRP) have emerged as independent predictors of
cardiovascular (CV) disease and type 2 diabetes. However, information linking low birth weight and hs-CRP in a
biracial (black/white) population is scant. We assessed a cohort of 776 black and white subjects (28% black, 43%
male) aged 24-43 years (mean 36.1 years) enrolled in the Bogalusa Heart Study with regard to birth weight and
gestational age data were retrieved from Louisiana State Public Health Office.
Findings: Black subjects had significantly lower birth weight than white subjects (3.145 kg vs 3.441 kg, p < 0.0001)
and higher hs-CRP level (3.29 mg/L vs 2.57 mg/L, p = 0.011). After adjusting for sex, age, body mass index (BMI),
smoking status and race (for total sample), the hs-CRP level decreased across quartiles of increasing birth weight in
white subjects (p = 0.001) and the combined sample (p = 0.002). Adjusting for sex, age, BMI, smoking status and
race for the total sample in a multivariate regression model, low birth weight was retained as an independent
predictor variable for higher hs-CRP levels in white subjects (p = 0.004) and the total sample (p = 0.007).
Conversely, the area under the receiver operative curve (c statistic) analysis adjusted for race, sex, age, smoking
status and BMI yielded a value of 0.777 with regard to the discriminating value of hs-CRP for predicting low birth
weight.
Conclusions: The deleterious effect of low birth weight on systemic inflammation depicted by the hs-CRP levels in
asymptomatic younger adults may potentially link fetal growth retardation, CV disease and diabetes, with
important health implications.
Background
The growth of an undernourished fetus results in adap-
tive fetal programming or metabolic imprinting, with
permanent changes in structure, metabolism and phy-
siology of fetal organs and related pathophysiologic con-
sequences in later life [1,2]. Studies worldwide,
regardless of socio-economic background, have linked
low birth weight to cardiometabolic risk factors, related
cardiovascular (CV) disease, and type 2 diabetes [3,4].
Recently, we reported the adverse relationship of low
birth weight to white blood cell count and pulsatile
arterial function [5,6].
Inflammation plays an important role in the pathogen-
esis of atherosclerosis [7-9]. Risk factors, e.g. cigarette
smoking, hypertension, dyslipidemia and hyperglycemia
promote inflammation, are well established. Biomarkers,
including as oxidized low-density lipoproteins, interleu-
kin-6, intercellular adhesion molecule-1 and high sensi-
tivity C-reactive protein (hs-CRP, reflect the ongoing
inflammatory process [8]. Of these, hs-CRP - an acute-
phase reactant secreted by the liver - has emerged as an
independent predictor of CV disease and type 2 diabetes
[8-13]. In terms of birth weight, a few studies have
demonstrated an inverse association between birth
weight and hs-CRP in children and adults [14-16]. Con-
sequently, the American Heart Association and Center
for Disease Control recommended guidelines for the
incorporation of hs-CRP into its CV disease risk
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regard are scant. The present study examines this aspect
in younger adults enrolled in the Bogalusa Heart Study,
a biracial (35% black/65% white) community-based
investigation of the natural history of CV disease
Materials and methods
Study Population
The study sample was derived from a cohort of 1203
subjects aged 23 to 43 examined as a part of a longitudi-
nal follow-up survey. Of these, information on 908 sin-
gletons with hs-CRP measurement, birth weight,
gestational age and body mass index (BMI) data were
available. The exclusion of 132 singletons born prema-
ture (<37 weeks of gestation) and/or had conditions
(with or without medication) of diabetes, hypertension
and dyslipidemia left 776 eligible participants (28%
black, 43% male, mean age 36.1 years). Birth weight and
gestational age data were retrieved from Louisiana State
Public Health Office. Tulane University Medical Center
Institutional Review Board approved the study, and
informed consent was obtained from all participants.
Measurements
Standardized techniques and protocols were used by
trained examiners. Height and weight were measured
twice and the mean values were used to calculate BMI
as a measure of adiposity. Information on smoking sta-
tus was obtained by questionnaires. Those who had
smoked at least one cigarette per week during the past
one year or more were identified as current smokers,
and the remainder as non-smokers. Plasma high sensi-
tivity hs-CRP levels were measured by latex particle-
enhanced immunoturbidemetric assay on a Hitachi 902
Automatic Analyzer (Roche Diagnostics, Indianapolis,
IN, USA). The reproducibility of hs-CRP measurement
checked with 10% of randomly assigned pairs of blind
duplicate analysis, which gave an intraclass correlation
coefficient of 0.99.
Statistical Methods
Statistical analyses were done with SAS software, version
9.1 (SAS, Carey, NC). As the hs-CRP level was not nor-
mally distributed, log transformation was used to
approach normality. Analyses were performed where
appropriate on transformed data. Analysis of variance
for race difference in mean values of continuous vari-
ables and chi-square test for categorical variables were
used. Because of a strong association between gesta-
tional age and birth weight, the latter was adjusted by
regression analysis models to the mean values of the
former in each race-sex group. For categorical analysis,
quartiles of gestational age-adjusted birth weight were
defined by using cut-off points in race-sex groups.
Covariates adjusted mean values of hs-CRP were calcu-
lated by general linear models and used for analysis of
birth weight by quartiles. Multiple regression analysis
was used to determine the independent association of
birth weight with hs-CRP in relation to the measured
covariates. Two steps were followed in the regression
model: the logarithm of hs-CRP was used in both cases
as a dependent variable to determine the association
between birth weight and hs-CRP. Model 1 was adjusted
for age, sex, smoking and race (for the total sample) and
the model 2 was adjusted for the above variables along
with the potential confounding variable, BMI. In addi-
tion, a multivariate c-statistic model was used to deter-
mine the ability of hs-CRP to predict low birth weight
(defined as <2500 gm). The area under the receiver-
operating characteristic curve (c-statistic) was evaluated
after adjusting for the covariates race, sex, age, smoking
status and BMI. C-statistic of >0.5 indicated increased
predictive ability.
Results
Table 1 shows the mean values of hs-CRP, birth weight,
and other study variables of younger adults by race.
Black subjects had significantly lower gestational age
and birth weight, but higher BMI and hs-CRP levels,
than white subjects.
Figure 1 illustrates the relation of covariates-adjusted
mean levels of hs-CRP to race- and sex-specific quartiles
of gestational age-adjusted birth weight. The covariates
included race (for the total sample), sex, age, BMI and
smoking status. The hs-CRP level significantly decreased
with increasing quartiles of birth weight among white
subjects (p = 0.001) and the total sample (p = 0.002).
Black subjects showed no such significant trend.
Table 2 presents the multivariate linear regression
analysis of hs-CRP on gestational age-adjusted birth
weight and other covariates in white subjects, black sub-
jects and the total sample. Birth weight was indepen-
dently and inversely associated with hs-CRP in white
subjects in models without or with BMI as a covariate.
Table 1 Birth Weight, hs-CRP and other study variables
of young adults by race
White
(n = 559)
Black
(n = 217)
p-value
b
Age (year)
a 36.3 (4.3) 35.8 (4.7) 0.200
Males/Females (%) 46/54 35/65 —————
BMI (kg/m
2)
a 28.3 (6.3) 30.5 (7.8) <0.0001
Gestational age (week)
a 40.1 (1.2) 39.8 (1.0) 0.001
Birth weight (kg)
a 3.441 (0.48) 3.154 (0.47) <0.0001
hs-CRP (mg/L)
a 2.57 (3.1) 3.29 (3.5) 0.011
Smoker (%) 44.1 40.3 0.327
aMean (SD).
bp value for race difference.
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tion was noted only in model 2 that included BMI as a
covariate. Also, sex (females > males), BMI (positive
association), and smoking (positive association) were
independently correlated with hs-CRP in white subjects
and the total sample in model 2.
Figure 2 shows the discriminative value of hs-CRP for
associating with low birth weight, after adjusting for
race, sex, age, smoking status and BMI. The c-value for
hs-CRP was 0.777.
Discussion
This community-based study demonstrates an inverse
and independent association between birth weight and
hs-CRP, a widely used biomarker of systemic inflamma-
tion. In addition, female sex, BMI and smoking were
independent adverse correlates of hs-CRP. It is note-
worthy that these findings support the emerging concept
of intrauterine imprinting and its pathophysiologic con-
sequences later in life by linking low birth weight to
excess hs-CRP [1,2].
Although previous study in children has failed to find
significant association between birth weight and hs-CRP
[16], our epidemiologic study is consistent with the
MIDSPAN family study and Northern Finland 1966
birth cohort study in adults [14,15]. However, this
inverse relationship was not observed in black subjects
in our analysis. Of note, black subjects had significantly
lower birth weights and related higher hs-CRP levels
than white subjects [17,18].
Although observational studies like this cannot
address the issue of causality, several putative mechan-
isms might link low birth weight to underlying perturba-
tion in inflammatory pathways in utero. Undernutrition
in utero causes permanent impairment in growth, struc-
ture, and function of muscle [19,20], fat [21,22], liver
[23] and renal nephrons [9,24] inter alia due to adaptive
programming, resulting in cardiometabolic syndrome
and related disorders in later life [3,25]. Interestingly, in
utero muscle growth is retarded in low-birth weight
babies [25]; and since there is little muscle cell replica-
tion after birth [26], these individuals will develop a dis-
proportionately high fat mass and related state of
chronic low-grade inflammation induced by adipose tis-
sue cells including monocytes in a nutritionally-rich
environment of postnatal life [25,27]. Acute-phase reac-
tants secreted by the liver, including hs-CRP, are upre-
gulated by interleukin-6, a proinflammatory cytokine
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Figure 1 Covariates-adjusted mean values of hs-CRP by race
and sex-specific quartiles of gestational age-adjusted birth
weight: The Bogalusa Heart Study. Quartile I represents the
lowest birth weight, and quartile IV represents the highest birth
weight. Covariates included race (for the total sample), sex, age,
body mass index and smoking status.
Table 2 Predictors of hs-CRP in young adults by race
White Black All
ß p-value ß p-value ß p-value
Model 1
Black race —— ———— ———— ———— 0.18 0.08
Age (year) -0.0005 0.97 0.03 0.10 0.008 0.41
Female sex 0.42 <0.0001 0.38 0.04 0.41 <0.0001
Smoking (yes) 0.15 0.14 -0.35 0.05 0.01 0.87
Birth weight (kg)
a -0.22 0.05 0.03 0.67 -0.14 0.13
Model 2
Black race —— —— ——— ——— -0.01 0.90
Age (year) 0.01 0.26 0.02 0.25 0.01 0.15
Female sex 0.50 <0.0001 0.26 0.12 0.43 <0.0001
Smoking (yes)
Birth weight (kg)
a
0.30
-0.28
0.002
0.004
-0.12
-0.13
0.48
0.47
0.19
-0.23
0.02
0.007
BMI (kg/m
2) 0.08 <0.0001 0.07 <0.0001 0.08 <0.0001
The Bogalusa Heart Study.
aGestational age-adjusted birth weight.
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Page 3 of 5synthesized by adipose tissue and cleared mainly by the
kidneys. Hence, adaptive programming of any of these
tissues may result in heightened inflammatory states
later in life. Of note, Barker et al. [28] demonstrated an
inverse relationship between birth weight and acute-
phase reactant fibrinogen in adults. Furthermore, studies
including our own have shown an inverse relationship
between birth weight and the number of circulating leu-
kocytes [5,29], the cellular effectors of inflammation.
However, a caveat relating to causality, is that the
observed elevation in hs-CRP levels among low birth
weight adults may be a reverse causation phenomenon
secondary to underlying excess atherosclerosis [30,31].
As in previous studies [18,32], obesity measured as
BMI has been identified as an independent correlate of
hs-CRP in our cohort. As discussed above, this is consis-
tent with the pathophysiological role of adipose tissue in
regulating inflammation. Furthermore, sex, but not race,
was retained as an independent correlate of hs-CRP in
our subjects. The excess in hs-CRP in females, also
noted in previous study [18], may be due to an estrogen
effect [33]. Based on exogenous estrogen administration
studies in women, this hormone has been implicated in
the transcriptional control, clearance, or cytokine regula-
tion of several acute-phase reactants produced by the
liver, including hs-CRP [34], but the role of endogenous
estrogen in this regard is unknown. The current obser-
vations on white and total subjects also support the
known adverse influence of smoking behavior on hs-
CRP levels [35]. The lack of adverse effect of smoking
among black subjects may be due to differences in
intensity and duration of smoking.
In conclusion, low birth weight for gestational age is
characterized by increased hs-CRP levels. In conjunction
with earlier studies, these findings support the view that
low birth weight, albeit a crude surrogate indicator of
adaptive fetal programming, is a potential early risk
factor for the emergence of disorders related to the acti-
vation of inflammatory pathways. As stated by Barker
[1], primary prevention lies in protecting fetal
development.
Abbreviations
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